AHA Coding Clinic® for HCPCS - 2004 Issue 2; FOR your INFORMATION
Additional outpatient services now eligible for payment
In a recent news release by the Centers for Medicare & Medicaid Services (CMS) on April 6, 2004, CMS has authorized hospitals to receive special payments for three additional drugs under the Outpatient Prospective Payment System (OPPS). The drugs identified for the special pass-through payments are as follows: Daptomycin—an injectable antibiotic for serious staph infections. Hospitals will receive payment of $0.31 per l mg; Risperidone—an injectable antipsychotic. Hospitals will receive payment of $131.86 per 12.5 mg; and Rasburicase—an injectable treatment for high uric acid levels that may result from certain cancer treatments. Hospitals...
To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.
Thank you for choosing Find-A-Code, please Sign In to remove ads.